Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboulker, J. P., & Swart, A. M. (1993). Preliminary analysis of the Concorde trial. Lancet, 341, 889–890.
Adachi, A., Fleming, I., Burk, R. D., Ho, G. Y., & Klein, R. S. (1993). Women with immunodeficiency virus infection and abnormal Papanicolaou smears: A prospective study of colposcopy and clinical outcome. Obstetrics and Gynecology, 81, 372–377.
American College of Obstetrics and Gynecology. (1992). Human immunodeficiency virus infections (Tech. Bull. No. 165). Chicago: Author.
American Public Health Association. (1991, January). Women and HIV disease: A report of the special initiative on AIDS. Washington, DC: Author.
Araneta, M. R. G., Weisfuse, I. B., Greenberg, B., Schultz, S., & Thomas, P. A. (1992). Abortions and HIV-1 infection in New York City, 1987–1989 AIDS, 6, 1195–1201
Bastian, L., Bennett, C. L., Adams, J., Waskin, H., Divine, G., & Edlin, B. R. (1993). Differences between men and women with HIV-related Pneumocystis carinii pneumonia: Experience from 3,070 cases in New York City in 1987. Journal of Acquired Immune Deficiency Syndromes, 6(6), 617–623.
Beevor, A. S., & Catalan, J. (1993). Women’s experience of HIV testing: The views of HIV positive and HIV negative women. AIDS Care, 5(2), 177–186.
Beral, V., Peterman, T. A., Berkelman, R. L., & Jaffe, H. W. (1990). Kaposi’s sarcoma among persons with AIDS: A sexually transmitted infection? Lancet, 335,123–128.
Biggar, R. J., Pahwa, S., Minkoff, H., Mendes, H., Willoughby, A., Landesman, S., & Goedert, J. J. (1989). Immunosuppression in pregnant women infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology, 161, 1239–1244.
Blaxhult, A., Granath, F., Lidman, K., & Giesecke, J. (1990). The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS, 4, 125–130.
Boekeloo, B. O., Rabin, D. L., Coughlin, S. S., Labbok, M. H., & Johnson, J. C. (1993). Knowledge, attitudes, and practices of obstetrician-gynecologists regarding the prevention of human immunodeficiency virus infection. Obstetrics and Gynecology, 81, 131–136.
Brettle, R. P., & Leen, C. L. S. (1991). The natural history of HIV and AIDS in women. AIDS, 5, 1283–1292.
Buehler, J. W., Hanson, D. L., & Chu, S. Y. (1992). The reporting of HIV/AIDS deaths in women. American Journal of Public Health, 82, 1500–1505.
Carpenter, C. C., Mayer, K. H., Fisher, A., Desai, M. B., & Durand, L. (1989). Natural history of acquired immunodeficiency syndrome in women in Rhode Island. American Journal of Medicine, 86, 771–775.
Carpenter, C. C., Mayer, K. H., Stein, M. D., Leibman, B. D., Fisher, A., & Fiore, T. C. (1991). Human immunodeficiency virus infection in North American women: Experience with 200 cases and a review of the literature. Medicine (Baltimore), 70(5), 307–325.
Castro, K. G., Lifson, A. R., White, C. R., Bush, T. S., Chamberland, M. E., Lekatsas, A. M., & Jaffe, H. W. (1988). Investigations of AIDS patients with no previously identified risk factors. Journal of the American Medical Association, 259, 1338–1342.
Catania, J. A., Coates, T. J., Stall, R., Turner, H., Petersen, J., Hearst, N., Dolcini, M. M., Hudes, E., Gagnon, J., Wiley, J., & Groves, R. (1992). Prevalence of AIDS-related risk factors and condom use in the United States. Science, 258, 1101–1106.
Centers for Disease Control. (1981). Follow-up on Kaposi’s sarcoma and Pneumocystis pneumonia. Morbidity and Mortality Weekly Report, 30, 409–410.
Centers for Disease Control. (1987). AIDS Weekly Surveillance Report, Atlanta: Author.
Centers for Disease Control. (1990). Screening for tuberculosis and tuberculosis infection in high-risk populations and the use of preventive therapy for tuberculosis infection in the United States. Morbidity and Mortality Weekly Report, 39, 409–410.
Centers for Disease Control. (1991). Premarital sexual experience among adolescent women—United States, 1970–1988. Morbidity and Mortality Weekly Report, 39, 929–931.
Centers for Disease Control. (1992a). Projections of the number of person diagnosed with AIDS and the number of immunosuppressed HIV-infected person—United States, 1992–1994. Morbidity and Mortality Weekly Report, 41, 1–29.
Centers for Disease Control. (1992b). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 1–19.
Centers for Disease Control. (1992c). Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morbidity and Mortality Weekly Report, 41, 1–11.
Centers for Disease Control. (1993a). Update: Mortality attributable to HIV infection among persons aged 25–44 years—United States, 1991 and 1992. Morbidity and Mortality Weekly Report, 42, 869–872.
Centers for Disease Control. (1993b). Update: Acquired immunodeficiency syndrome—United States, 1992. Morbidity and Mortality Weekly Report, 42, 547–557.
Centers for Disease Control. (1993c). Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. Morbidity and Mortality Weekly Report, 42, 1–18.
Centers for Disease Control. (1993d). 1993 Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report: Recommendations and Report, 14,42, 89–91.
Centers for Disease Control. (1993e). Recommendation on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. Morbidity and Mortality Weekly Report, 42, 14–20.
Centers for Disease Control. (1993f). Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings and technical guidance on HIV counseling. Morbidity and Mortality Weekly Report, 42, 1–17.
Centers for Disease Control. (1994a). National HIV serosurveillance—Summary—Results through 1992. (Vol.3).
Centers for Disease Control. (1994b). Zidovudine for the prevention of HIV transmission from mother to infant. Morbidity and Mortality Weekly Report, 43, 285–287.
Centers for Disease Control. (1995). HIV/AIDS surveillance report, 7, 1–34.
Chaisson, R. E., Moss, A. R., Onishi, R., Osmond, D., & Carlson, J. R. (1987). Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health, 77, 169–172.
Chaisson, R. E., Taylor, E., Margolick, J. B., Muñoz, A., Solomon, L., Cohn, S., Nelson, K. E., & Vlahov, D. (1992). Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. Journal of Acquired Immune Deficiency Syndromes, 5, 456–460.
Chavkin, W. (1990). Preventing AIDS, targeting women. Health/PAC Bulletin, 20(1), 19–23.
Chu, S. Y., Buehler, J. W., & Berkelman, R. L. (1990). Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States. Journal of the American Medical Association, 264, 225–229.
Chu, S. Y., Conti, L., & Schable, C. (1994). Female to female sexual contact and HIV transmission. Journal of the American Medical Association, 272, 433.
Chu, S. Y., Hammett, T. A., & Buehler, J. W. (1992). Update: Epidemiology of reported cases of AIDS in women who report sex only with other women, United States, 1980–1991 AIDS, 6, 518–519.
Connor, E. M., Sperling, R. S., Gelber, R., Kiseley, P., Scott, G., O’Sullivan, M. J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R. L., Jimenez, E., O’Neill, E., Bazin, B., Delfraissy, J., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, P., & Balsey, J., for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type-I with zidovudine treatment. New England Journal of Medicine, 331, 1173–1180.
Cooper, D. A., Gatell, J. M., Kroon, S., Clumeck, N., Millard, J., Goebel, F. D., Bruun, J. N., Stingl, G., Melville, R. L., Gonz’alez-Lahoz, J., Stevens, J. W., Fiddian, A. P., & the European-Australian Collaborative Group. (1993). Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. New England Journal of Medicine, 329, 297–303.
Curran, J., Jaffe, H., Hardy, A., Morgan, W., Selik, R., & Dondero, T. (1988). Epidemiology of HIV infection and AIDS in the United States. Science, 239, 610–616.
Darrow, W., & the Centers for Disease Control Collaborative Group for the Study of HIV-1 in Selected Women. (1990). Prostitution, intravenous drug use, and HIV-1 in the United States. AIDS, Drugs, and Prostitution, 18–40.
Deschamps, M. M., Pape, J. W., Desvarieux, M., Williams-Russo, P., Madhaven, S., Ho, J. L., & Johnson, W. D. (1993). A prospective study of HIV-seropositive asymptomatic women of child-bearing age in adeveloping country. Journal of Acquired Immune Deficiency Syndromes, 6, 446–451.
Doll, L. S., Petersen, L. R., White, C. R., Ward, J. W., & the HIV Blood Donor Study Group. (1991). Human immunodeficiency virus type 1-infected blood donors: Behavioral characteristics and reasons for donation. Transfusion, 31, 704–709.
Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., Inciardi, J. A., Bowser, B. P., Schilling, R. F., Holmberg, S. D., & the Multicenter Crack Cocaine and HIV Infection Study Team. (1994). Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331, 1422–1427.
Ellerbrock, T. V., Bush, T. J., Chamberland, M. E., & Oxtoby, M. J. (1991). Epidemiology of women with AIDS in the United States, 1981–1990 A comparison with heterosexual men with AIDS. Journal of the American Medical Association, 265, 2971–2975.
Ellerbrock, T. V., Harrington, P. E., Bush, T. J., Schoenfisch, S. A., Oxtoby, M. J., & Witte, J. J. (1995). Risk of human immunodeficiency virus infection among pregnant crack-cocaine users in a rural community. Obstetrics and Gynecology, 86, 400–404.
Ellerbrock, T., Wright, T. C., Chaisson, M. A., Bush, T. J., & the Cervical Disease Study Group. (1993). Strong independent association between HIV infection and cervical intraepithelial neoplasia (CIN). Abstracts of the IXth International Conference on AIDS (Abstract No. WS-B07-5). Berlin.
Farizo, K. M., Buehler, J. W., Chamberland, M. E., Whyte, B. M., Froelicher, E. S., Hopkins, S. G., Reed, C. M., Mokotoff, E. D., Cohn, D. L., Troxler, S., Phelps, A. P., & Berkelman, R. L. (1992). Spectrum of disease in persons with human immunodeficiency virus infection in the United States. Journal of the American Medical Association, 267, 1798–1805.
Feingold, A. R., Vermund, S. H., Burk, R. D., Kelley, K. F., Schrager, L. K., Schreiber, K., Munk, G., Friedland, G. H., & Klein, R. S. (1990). Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes, 3, 896–903.
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Milddvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King, D., & the AZT Collaborative Working Group. (1987). The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 317,185–191.
Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. J., Para, M. F., Hardy, W. D., Dolin, R., Powderly, W. G., Allan, J. D., Wong, B., Merigan, T. C., McAuliffe, V. J., Hyslop, N. E., Rhame, F. S., Balfour, H. H., Spector, S. A., Volberding, P., Pettinelli, C., Anderson, J., & the AIDS Clinical Trials Group. (1990). The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: A double-blind, placebo-controlled trial. Annals of Internal Medicine, 112, 727–737.
Flanigan, T. P., Imam, N., Lange, N., Fiore, T., Hoy, J., Stein, M., & Carpenter, C. C. (1992). Decline of CD4 lymphocyte counts from the time of seroconversion in HIV-positive women. Journal of Women’s Health, 1(3), 231–234.
Fleming, P. L., Ciesielski, C. A., Byers, R. H., Castro, K. G., & Berkelman, R. L. (1993). Gender differences in reported AIDS-indicative diagnoses. Journal of Infectious Diseases, 168(7), 61–67.
Fullilove, R. E., Fullilove, M., Bowser, B. P., & Gross, S. A. (1990). Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, California. Journal of the American Medical Association, 263, 851–855.
Goedert, J. J., Duli’ege, A. M., Amos, C. I., Felton, S., & Biggar, R. J. (1991). High risk of HIV-1 infection for first-born twins. Lancet, 338, 1471–1475.
Goedert, J. J., Kessler, C. M., Aledort, L. M., Biggar, R. J., Andes, W. A., White, G. C., Drummond, J. E., Vaidya, K., Mann, D. L., Eyster, M. E., Ragni, M. V., Lederman, M. M., Cohen, A. R., Bray, G. L., Rosenberg, P. S., Friedman, R. M., Hilgartner, M. W., Blattner, W. A., Kroner, B., & Gail, M. (1989). A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New England Journal of Medicine, 321, 1141–1148.
Greenberg, J., Magder, L., & Aral, S. (1992). Age at first coitus a marker for risky sexual behavior in women. Sexually Transmitted Diseuses, 19, 331–334.
Grossman, J. H., Nies, B. M., Lopez-Zeno, J., Bathgate, S. L., & Parenti, D. M. (1992). Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetalmedicine fellowship training programs. Obstetrics and Gynecology, 80, 985–988.
Gwinn, M., Wasser, S., Fleming, P., Karon, J., & Petersen, L. (1993, June). Increasing prevalence of HIV infection among childbearing women, United States, 1989–1991. Paper presented at the Ninth International Conference on AIDS, Berlin.
Hahn, R. A., Onorato, I. M., Jones, S., & Doughtery, I. (1989). Prevalence of HIV infection among intravenous drug users in the United States. Journal of the American Medical Association, 261, 2677–2684.
Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., Day, P. L., Diamond, G. R., Dickinson, G. M., Drusano, G. L., Egorin, M. J., George, W. L., Gordin, F. M., Hawkes, C. A., Jensen, P. C., Klimas, N. G., Labriola, A. M., Lahart, C. J., O’Brien, W. A., Oster, C. N., Weinhold, K. J., Wray, N. P., Zolla-Pazner, S. B., & the Veterans Affairs Cooperative Study Group on AIDS Treatment. (1992). A controlled trial of early versus late treatment with zidovudine in symptomatic human immuno-deficiency virus infection: Results of the Veterans Affairs Cooperative Study. New England Journal of Medicine, 326, 437–443.
Hoegsberg, B., Abulafia, O., Sedlis, A., Feldman, J., DesJarlais, D., Landesman, S., & Minkoff, H. (1990). Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. American Journal of Obstetrics and Gynecology, 163, 1135–1139.
Holmberg, S. C., Horsburgh, C. R., Ward, J. W., & Jaffe, H. W. (1989). Biological factors in the sexual transmission of human immunodeficiency virus. Journal of Infectious Diseases, 160, 116–125.
Imam, N., Carpenter, C. C., Mayer, K. H., Fisher, A., Stein, M., & Danforth, S. B. (1990). Hierarchical pattern of mucosal candida infection in HIV-infected women. American Journal of Medicine, 89(2), 142–146.
Irwin, K., O’Sullivan, M., Sperling, R., Brodman, M., Moorman, A., & the Multicenter HIV and PID Study Group. (1993). The microbiologic etiology of pelvic inflammatory disease (PID) in HIV+ and HIV-women: Preliminary findings of a multicenter study. Abstracts of the IXth International Conference on AIDS (Abstract No. WS-B07-1). Berlin.
Jensen, L. P., O’Sullivan, M. J., Gomez-Del-Rio, Setzer, E. S., Gaskin, C., & Penso, C. (1985). Acquired immunodeficiency syndrome (AIDS) in pregnancy. American Journal of Obstetrics and Gynecology, 148, 1145–1146.
Jewett, J. F., & Hecht, F. M. (1993). Preventive health care for adults with HIV infection. Journal of the American Medical Association, 269, 1144–1153.
Kaslow, R. A., Blackweider, W. C., Ostrow, D. G., Yerg, D., Palenicek, J., Coulson, A. H., & Valdiserri, R. O. (1989). No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals: A report from the Multicenter AIDS Cohort Study. Journal of the American Medical Association, 261, 3424–3429.
Kinloch-de Loës, S., de Saussure, P., Saurat, J.-H., Stalder, H., Hirschel, B., & Perrin, L. H. (1993). Symptomatic primary infection due to human immunodeficiency virus type 1: Review of 31 cases. Clinical Infectious Diseases, 17(1) 59–65.
Lange, W. R., Snyder, F. R., Lozovsky, D., Kaistha, V., Kaczaniuk, M. A., Jaffe, J. H., & the AIDS Epidemiology Collaborating Group. (1988). Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. American Journal of Public Health, 78, 443–446.
Lemp, G. F., Hirozawa, A. M., Cohen, J. B., Derish, P. A., McKinney, K. C., & Hernandez, S. R. (1992). Survival for women and men with AIDS. Journal of Infectious Diseases, 166(1), 74–79.
Lemp, G. F., Payne, S. F., Neal, D., Temelso, T., & Rutherford, G. W. (1990). Survival trends for patients with AIDS. Journal of the American Medical Association, 263, 402–406.
Levine, C. (1990). Women and HIV/AIDS research: The barriers to equity. Evaluation Review, 14, 447–463.
Lewis, D. K., & Waters, J. K. (1991). Sexual risk behavior among heterosexual intravenous drug abusers: Ethnic and gender variation. AIDS, 5, 77–83.
Lifson, A. R., Hessol, N. A., & Rutherford, G. W. (1992). Progression and clinical outcome of infection due to human immunodeficiency virus. Clinical Infectious Diseases, 14, 966–971.
Lindan, C. P., Allen, S., Serufilira, A., Lifson, A. R., Van de Perre, P., Chen-Rundle, A., Batungwanayo, J., Nsengumuremyi, F., Bogaerts, J., & Hulley, S. (1992). Predictors of mortality among HIV-infected women in Kigali, Rwanda. Annals of Internal Medicine, 116(4), 320–328.
Lurie, N., Ward, N., Shapiro, M., Gallego, C., Vaghaiwalla, R., & Brook, R. H. (1986). Termination of Medi-Cal benefits, a follow-up study one year later. New England Journal of Medicine, 314, 1266–1268.
Maiman, M., Fruchter, R. G., Serur, E., Levine, P. A., Arrastia, C. D., & Sedlis, A. (1993). Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus seropositive women. Obstetrics and Gynecology, 81, 170–174.
Maiman, M., Tarricone, N., Vieira, J., Suarez, J., Serur, E., & Boyce, J. C. (1991). Colposcopic evaluation of human immunodeficiency virus seropositive women. Obstetrics and Gynecology, 78(1), 84–88.
Marmor, M., Weiss, L. R., Lyden, M., Weiss, S. H., Saxinger, W. C., Spira, T. J., & Feorino, P. M. (1986). Possible female-to-female transmission of human immunodeficiency virus [Letter to the editor]. Annals of Internal Medicine, 105, 969.
Masur, H., Michelis, M. A., Wormser, G. P., Lewin, S., Gold, J., Tapper, M. L., Giron, J., Lerner, C. W., Armstrong, D., Setia, U., Sender, J. A., Siebken, R. S., Nicholas, P., Arlen, Z., Maayan, S., Ernst, J. A., Siegel, F. P., & Cunningham-Rundles, S. (1982). Opportunistic infection in previously healthy women: Initial manifestations of a community-acquired cellular immunodeficiency. Annals of Internal Medicine, 97, 533–539.
Medley, G. F., Anderson, R. M., Cox, D. R., & Billard, L. (1987). Incubation period of AIDS in patients infected via blood transfusion. Nature, 328, 719–721.
Melnick, S. L., Sherer, R., Louis, T. A., Hillman, D., Rodriguez, E. M., Lackman, C., Capps, L., Brown, L. S., Carlyn, M., Korvick, J. A., & Deyton, L., for the Terry Beirn Community Programs for Clinical Research on AIDS. (1994). Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. Journal of the American Medical Association, 272, 1915–1921.
Miller, H. G., Turner, C. F., & Moes, L. (Eds.). (1990). AIDS: The second decade. Washington, DC: National Academy Press.
Minkoff, H. L., & DeHovitz, J. A. (1991). Care of women infected with the human immunodeficiency virus. Journal of the American Medical Association, 266, 2253–2258.
Minkoff, H. L., & Moreno, J. D. (1990). Drug prophylaxis for human immunodeficiency virus infected pregnant women: Ethical considerations. American Journal of Obstetrics and Gynecology, 163, 1111–1113.
Minkoff, H., Nanda, D., Menez, R., & Kikhig, S. (1987). Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: Follow-up of mothers, children, and subsequently born siblings. Obstetrics and Gynecology, 69 (3, Pt. 1), 288–291.
Mondanaro, J. (1990). Community-based AIDS prevention interventions: Special issues of women intravenous drug users. In C. Leukefeld, R. Battjes, & Z. Amsel (Eds.), AIDS and intravenous drug use: Future directions for community-based prevention research (NIDA Research Monograph No. 93, pp. 68–82). Rockville, MD: National Institute on Drug Abuse.
Monzon, O. T., & Capellan, J. M. B. (1987). Female-to-female transmission of HIV [Letter to the editor]. Lancet, 2, 40–41.
Moore, R. D., Stanton, D., Gopalan, R., & Chaisson, R. E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330, 763–768.
Moorman, A., Rice, R., Irwin, K., O’Sullivan, M., Sperling, R., Grodman, M., & the Multicenter HIV and PID Study Group. (1993). The clinical presentation and course of pelvic inflammatory disease in HIV+ and HIV—women: Preliminary results of a multicenter study. Abstracts of the IXth International Conference on AIDS (Abstract No. PO-B23-1937). Berlin.
Morlat, P., Parniex, P., Douard, D., Lacosta, D., Dupon, M., Chene, G., Pellegrin, J. L., Raynaud, J. M., & Dabis, F. (1992). Women and HIV infection: A cohort study of 483 HIV-infected women in Bourdeaux, France, 1985–1991. AIDS, 6, 1187–1193.
Moss, A. R., & Bacchetti, P. (1989). Natural history of HIV infection. AIDS, 3(2), 55–61.
Muller, C. (1988). Medicaid: The lower tier of health care for women. Women and Health, 14(2), 81–103.
National Center for Health Statistics. (1993a). Physician contacts, according to place of contact and selected patient characteristics: United States, 1986 and 1991. Health United State, —1992, p. 117.
National Center for Health Statistics. (1993b). Interval since last physician contact, according to selected patient characteristics: United States, 1986 and 1991. Health United State, —1992, p. 118.
National Center for Health Statistics. (1994). Annual summary of births, marriages, divorces, and deaths: United States, 1993. Monthly Vital Statistics Report, 42. Hyattsville, MD: Public Health Service.
National Institutes of Allergy and Infectious Diseases/National Institutes of Health. State-of-the-Art Conference. (1990). AZT therapy for early HIV infection. Clinical Courier, 8, 1–8.
National Institutes of Allergy and Infectious Diseases. (1991, March). ACTG Protocol 076-Questions and answers. Backgrounder.
Nightingale, S. D., Cameron, W., Gordin, F. M., Sulam, P. M., Cohn, D. L., Chaisson, R. E., Eron, L. J., Sparti, P. D., Bihari, B., Kaufman, D. L., Stern, J. J., Pearce, D. D., Weinberg, W. G., LaMarca, A., & Siegle, F. P. (1993). Two controlled trials of Rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. New England Journal of Medicine, 329, 828–833.
Novick, L. F., Glebatis, D. M., Stricof, R. L., MacCubbin, P. A., Lessner, L., & Berns, D. S. (1991). Newborns seroprevalence study: Methods and results. American Journal of Public Health, 81, 15–21.
O’Sullivan, M. J., Boyer, P. J., Scott, G. B., Parks, W. P., Weller, S., Blum, M. R., Balsely, J., Bryson, Y. J., and the Zidovudine Collaborative Working Group. (1993). The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). American Journal of Obstetrics and Gynecology, 168, 1510–1516.
Padian, N., Shiboski, S., & Jewell, N. (1990, June). The relative efficiency offemale-to-male HIV sexual transmission. Paper presented at the Sixth International Conference on AIDS, San Francisco.
Perry, S., Jacobsberg, L., & Fogel, K. (1989). Orogenital transmission of HIV. Annals of Internal Medicine, 111, 951–952.
Quinn, T. C., Glaser, D., Cannon, R., Matuszak, D., Dunning, R., Kline, R., Campbell, C., Israel, E., Fauci, A., & Hook, E. (1988). Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. New England Journal of Medicine, 318, 197.
Rhoads, J. L., Wright, C., Redfield, R. R., & Burke, D. S. (1987). Chronic vaginal candidiasis in women with human immunodeficiency virus infection. Journal of the American Medical Association, 257, 3105–3107.
Rothenberg, R., Woelfel, M., Stoneburner, R., Milberg, J., Parker, R., & Truman, B. (1987). Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City. New England Journal of Medicine, 317, 1297–1302.
Royce, R. A., & Winklestein, W. (1990). HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: Preliminary results from the San Francisco Men’s Health Study. AIDS, 4, 327–333.
Rutherford, G. W., Lifson, A. R., Hessol, N. A., Darrow, W. W., O’Malley, P. M., Buchbinder, S. P., Barnhart, J. L., Bodecker, T. W., Cannon, L., Doll, L. S., Holmberg, S. D., Harrison, J. S., Rogers, M. F., Werdegar, D., & Jaffe, H. W. (1990). Course of HIV-1 infection in a cohort of homosexual and bisexual men: An 11-year follow-up study. British Medical Journal, 301, 1183–1188.
Schafer, A., Friedmann, W., Mielke, M., Schwartlander, B., & Koch, M. A. (1991). The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. American Journal of Obstetrics and Gynecology, 164, 593–599.
Schoenbaum, E. E., & Webber, M. P. (1993). The underrecognition of HIV infection in women in an inner-city emergency room. American Journal of Public Health, 83, 363–368.
Scott, G. B., Fischl, M. A., Klimas, N., Fletcher, M. A., Dickinson, G. M., Levine, R. S., & Parks, W. P. (1985). Mothers of infants with the acquired immunodeficiency syndrome. Journal of the American Medical Association, 253, 363–366.
Seage, G. R., Oddleifson, S., Carr, E., Shea, B., Makarewicz-Robert, L., van Beuzekom, M., & De Maria, A., (1993). Survival with AIDS in Massachusetts, 1979 to 1989. American Journal of Public Health, 83, 72–78.
Seidman, S. N., Mosher, W. D., & Aral, S. O. (1992). Women with multiple sexual partners: United States, 1988. American Journal of Public Health, 82, 1388–1394.
Selik, R. M., Chu, S. Y., & Buehler, J. W. (1993). Human immunodeficiency virus infection as the leading cause of death among young adults in U.S. cities and states. Journal of the American Medical Association, 269, 2991–2994.
Selwyn, P. A., Alcabes, P., Hartel, D., Buono, D., Schoenbaum, E. E., & Klein, R. S., Davenny, L., & Friedland, G. H. (1992). Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1697–1703.
Shah, P. N., Smith, J. R., Wells, C., Barton, S. E., Kitchen, V. S., & Steer, P. J. (1994). Menstrual symptoms in women infected by the human immunodeficiency virus. Obstetrics and Gynecology, 83, 397–400.
Shiboski, C. H., Hilton, J. F., Greenspan, D., Westenhouse, J. L., Derish, P., Vranizan, K., Lifson, A. R., Canchola, A., Katz, M. H., Cohen, J. B., Moss, A. R., & Greenspan, J. S. (1994). HIV-related oral manifestations in two cohorts of women in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 7, 964–971.
Smith, T. W. (1991). Adult sexual behavior in 1989. Numbers of partners, frequency of intercourse, and risk of AIDS. Family Planning Perspectives, 23, 102–106.
Soskolne, V., Aral, S. O., Magder, L. S., Reed, D. S., & Bowen, G. S. (1991). Condom use with regular and casual partners among women attending family planning clinics. Family Planning Perspectives, 23, 222–225.
Sperling, R. S., Steatton, P., O’Sullivan, M. J., Boyer, P., Watts, D. H., Lambert, J. S., Hammill, H., Livingston, E. S., Gloeb, D. J., Minkoff, H., & Fox, H. E. (1992). A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. New England Journal of Medicine, 326, 857–861.
Stein, M. D., Leibman, B., Wachtel, T. J., Carpenter, C. C., Fisher, A., Durand, L., O’Sullivan, P. S., & Mayer, K. H. (1991). HIV-positive women: Reasons why they are tested for HIV and their clinical characteristics on entry into the health care system. Journal of General Internal Medicine, 6(4), 286–289.
Stein, M. D., Piette, J., Mor, V., Wachtel, T. J., Fleishman, J., Mayer, K. H., & Carpenter, C. C. (1991). Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. Journal of General Internal Medicine, 6(1), 35–40.
Stokes, J. P., McKirnan, D. J., Doll, L., & Burzette, R. G. Female partners of bisexual men: What they don’t know might hurt them. Psychology of Women Quarterly (in press).
Stone, V. E., Seage, G. R., Hertz, T., & Epstein, A. M. (1992). The relation between hospital experience and mortality for patients with AIDS. Journal of the American Medical Association, 268, 2655–2661.
Styrt, B., & Sugarman, B. (1991). Estrogens and infection. Reviews of Infectious Diseases, 13, 1139–1150.
Sweeney, P. A., Onorato, I. M., Allen, D. M., Byers, R. H., & the Field Services Branch. (1992). Sentinel surveillance of human immunodeficiency virus infection in women seeking reproductive health services in the United States, 1988–1989. Obstetrics and Gynecology, 79, 503–510.
Tindall, B., & Cooper, D. A. (1991). Primary HIV infection: Host responses and intervention strategies. AIDS, 5(1), 1–14.
University of Massachusetts Law Center. (1992). Searching for women: A literature review on women, HIV and AIDS in the United States (pp. 92, 94). Boston: Author.
U.S. Bureau of the Census. (1989). Health insurance coverage status by selected characteristics, 1985. Statistical Abstract (p. 96).
Vermund, S. H., Galbraith, M. A., Ebner, S. C., Sheon, A. R., & Kawlow, R. A. (1992). Human immunodeficiency virus/acquired immunodeficiency syndrome in pregnant women. Annals of Epidemiology, 2, 773–803.
Vermund, S. H., Kelley, K. F., Klein, R. S., Feingold, A. R., Schreiber, K., Munk, G., & Burk, R. D. (1991). High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. American Journal of Obstetrics and Gynecology, 165, 392–400.
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hysloop, N. E., Richman, D. D., Valentine, F. T., Corey, L., & the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine, 322, 941–949.
Ward, J. W., Bush, T. J., Perkins, H. A., Lieb, L. E., Allen, J. R., Goldfinger, D., Samson, S. M., Pepkowitz, S. H., Fernando, L. P., Holland, P. V., Kleinman, S. H., Grindon, A. J., Gamer, J. L., Rutherford, G. W., & Holmberg, S. D. (1989). The natural history of transfusion-associated infection with human immunodeficiency virus: Factors influencing the rate of progression to disease. New England Journal of Medicine, 321, 947–952.
Ward, J. W., Kleinman, S. H., Douglas, D. K., Grindon, A. J., & Holmberg, S. D. (1988). Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus. Transfusion, 28(4), 298–301.
Wasser, S. C., Gwinn, M., & Fleming, P. (1993). Urban-nonurbandistribution of HIV infection in childbearing women in the United States. Journal of Acquired Immune Deficiency Syndromes, 6, 1035–1042.
Weber, R., Ledergerber, B., Opravil, M., Siegenthaler, W., & Lutley, R. (1990). Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. British Medical Journal, 301, 1362–1365.
Wright, T. C., Ellerbrock, T. V., Chaisson, M. A., Xun, X. W., Young, S., Bush, T., Dole, P., Van Devanter, N., Richart, R. M., Koulos, J., Brudney, K., Marte, C., Perez, G., & Johnson, E. (1994). Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Pap smears. Obstetrics and Gynecology, 84, 591–597.
Wright, T. C., Koulos, J., Schnoll, F., Swanbeck, J., Ellerbrock, T. V., Chaisson, M. A., & Richart, R. M. (1994). Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Outcome after loop electrosurgical excision. Gynecologic Oncology, 55, 253–258.
Xiao-Wei, S., Ellerbrock, T. V., Lungu, O., Chaisson, M. A., Bush, T. J., & Wright, T. C. (1995). Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstetrics and Gynecology, 85, 680–686.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Smith, D.K., Moore, J.S. (2002). Epidemiology, Manifestations, and Treatment of HIV Infection in Women. In: O’Leary, A., Jemmott, L.S. (eds) Women and AIDS. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/0-306-47140-X_1
Download citation
DOI: https://doi.org/10.1007/0-306-47140-X_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45258-1
Online ISBN: 978-0-306-47140-7
eBook Packages: Springer Book Archive